The Effect of Postpartum Kangaroo Father Care on Paternal Attachment

NCT ID: NCT05337215

Last Updated: 2025-03-13

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

90 participants

Study Classification

INTERVENTIONAL

Study Start Date

2020-02-14

Study Completion Date

2021-02-16

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Objective: This study was conducted in a randomized controlled manner to determine the effect of kangaroo care (KC) on paternal attachment (PA).

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Objective: This study was conducted in a randomized controlled manner to determine the effect of kangaroo care (KC) on paternal attachment (PA).

Design: The data for the study were collected using the introductory information form (IIF) and the father-infant attachment scale (FIAS). T test, Mann Whitney U test and Kruskal Wallis test were used for statistical analysis.

Participants and setting: A total of 90 fathers, including 45 in the intervention group and 45 in the control group who met the inclusion criteria of the study were included randomly.

Keywords: Kangaroo care; father; paternal attachment; Turkey.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Nursing Caries

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

FACTORIAL

Primary Study Purpose

HEALTH_SERVICES_RESEARCH

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Control group

While the IIF was applied to control group at the first meeting in the postpartum ward, FIAS was administered by phone or home visit in the third month after the face-to-face interview.There was any intervention for this group

Group Type ACTIVE_COMPARATOR

kangaroo father care

Intervention Type BEHAVIORAL

The effect of postpartum kangaroo father care on paternal attachment

kangaroo father care

While the IIF was applied to control group at the first meeting in the postpartum ward, FIAS was administered by phone or home visit in the third month after the face-to-face interview.. the first KC was applied within the first 4-6 hours after birth, and the second KC was applied in the postpartum ward under the supervision of the researcher on the first day after birth. The third KC was performed by the fathers themselves at home on the third postpartum day after discharge. Immediately afterwards, the researcher observed the father and baby from an appropriate distance, and the father and the baby had skin-to-skin contact for mean 15-20 minutes.

Group Type EXPERIMENTAL

kangaroo father care

Intervention Type BEHAVIORAL

The effect of postpartum kangaroo father care on paternal attachment

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

kangaroo father care

The effect of postpartum kangaroo father care on paternal attachment

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* fathers who are aged 18 and 50,
* married,
* voluntarily agree to participate in the study,
* have healthy babies,
* live with their babies.

Exclusion Criteria

* a history of chronic psychiatric illness
* antipsychotic medication use
* babies with premature / low birth weight / congenital anomalies
Minimum Eligible Age

18 Years

Maximum Eligible Age

50 Years

Eligible Sex

MALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Hitit University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Fatma Yildirim

Principal Investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Fatma Yıldırım

Çorum, Çorum, Turkey (Türkiye)

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Turkey (Türkiye)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

HititUniversity_2

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.